Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
AME 
Ametek Inc (AME)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/09/2025: AME (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
18 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $220.24
1 Year Target Price $220.24
| 10 | Strong Buy |
| 2 | Buy |
| 5 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 24.61% | Avg. Invested days 62 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 12/09/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 46.02B USD | Price to earnings Ratio 31.43 | 1Y Target Price 220.24 |
Price to earnings Ratio 31.43 | 1Y Target Price 220.24 | ||
Volume (30-day avg) 18 | Beta 1.05 | 52 Weeks Range 144.31 - 203.83 | Updated Date 12/8/2025 |
52 Weeks Range 144.31 - 203.83 | Updated Date 12/8/2025 | ||
Dividends yield (FY) 0.61% | Basic EPS (TTM) 6.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.5% | Operating Margin (TTM) 25.79% |
Management Effectiveness
Return on Assets (TTM) 7.49% | Return on Equity (TTM) 14.63% |
Valuation
Trailing PE 31.43 | Forward PE 26.88 | Enterprise Value 47895401733 | Price to Sales(TTM) 6.42 |
Enterprise Value 47895401733 | Price to Sales(TTM) 6.42 | ||
Enterprise Value to Revenue 6.69 | Enterprise Value to EBITDA 21.17 | Shares Outstanding 230203873 | Shares Floating 228900919 |
Shares Outstanding 230203873 | Shares Floating 228900919 | ||
Percent Insiders 0.37 | Percent Institutions 90.44 |
Upturn AI SWOT
Ametek Inc
Company Overview
History and Background
AMETEK, Inc. was founded in 1930. It has evolved from a diversified industrial manufacturer into a leading global manufacturer of electronic instruments and electromechanical devices. Key milestones include its strategic shift towards specialized niche markets and a consistent track record of acquisitions to expand its technological capabilities and market reach.
Core Business Areas
- Electronic Instruments Group (EIG): Designs and manufactures advanced analytical, monitoring, testing, calibrating, and display instruments. Products are used in a wide range of industries including oil and gas, medical, aerospace, power, environmental, and industrial automation.
- Electromechanical Group (EMG): Designs and manufactures advanced motors, motion control systems, specialized interconnects, and engineered materials. These products are critical for applications in aerospace, defense, medical, industrial, and automation markets.
Leadership and Structure
AMETEK operates with a decentralized structure, empowering its segment leaders and subsidiary management teams. The company is led by a Board of Directors and a senior executive team, including a Chairman and CEO, who oversee the strategic direction and financial performance of the organization. The organizational structure is designed to foster agility and focus on specific market niches.
Top Products and Market Share
Key Offerings
- Process Analyzers (EIG): High-performance analyzers for industrial processes, used in petrochemicals, power generation, and environmental monitoring. Competitors include Emerson Electric, Honeywell International, and Yokogawa Electric. Specific market share data is proprietary but AMETEK holds strong positions in niche segments.
- Medical Devices and Components (EIG/EMG): Specialized components and devices for medical equipment, including fluid management and respiratory devices. Competitors include Medtronic, Thermo Fisher Scientific, and Baxter International. AMETEK is a significant supplier of niche components.
- Aerospace and Defense Components (EMG): Electric motors, specialized interconnects, and other components for aircraft and defense systems. Competitors include Moog Inc., Meggitt PLC, and GE Aviation. AMETEK is a key supplier in specific aerospace and defense sub-sectors.
- Programmable Power Supplies (EIG): High-performance power supplies used in testing and measurement applications across various industries. Competitors include Keysight Technologies, National Instruments, and Chroma Systems. AMETEK is a recognized player in specialized programmable power solutions.
Market Dynamics
Industry Overview
AMETEK operates in highly specialized and fragmented industrial and electronic instrumentation markets. These markets are driven by innovation, demand for precision, reliability, and regulatory compliance. Key trends include digitalization, automation, increasing complexity of industrial processes, and demand for advanced materials.
Positioning
AMETEK is positioned as a leading global manufacturer of differentiated electronic instruments and electromechanical devices. Its strategy focuses on acquiring and growing niche businesses with strong market positions, proprietary technologies, and high barriers to entry. Its competitive advantages lie in its diversified portfolio, technological expertise, decentralized operating model, and consistent execution of its acquisition strategy.
Total Addressable Market (TAM)
The total addressable market for AMETEK's products spans multiple large and growing industries, including industrial automation, aerospace and defense, medical devices, and process control. While exact TAM figures are difficult to isolate for AMETEK's specific niches, the broader markets it serves are in the hundreds of billions of dollars globally. AMETEK is well-positioned within its chosen niche segments, often holding leading or number two positions.
Upturn SWOT Analysis
Strengths
- Strong portfolio of niche businesses with leading market positions.
- Proven track record of successful acquisitions and integration.
- Diversified revenue streams across multiple end markets.
- Technological expertise and commitment to innovation.
- Decentralized operating model fostering agility and focus.
Weaknesses
- Reliance on acquired companies for growth can lead to integration challenges.
- Exposure to cyclicality in some of its end markets (e.g., industrial).
- Potential for intense competition in certain product categories.
- Relatively high debt levels due to frequent acquisitions.
Opportunities
- Continued growth in key end markets such as aerospace, defense, and medical.
- Leveraging acquisitions to enter new high-growth technology areas.
- Expansion into emerging markets and geographies.
- Increasing demand for automation and advanced analytical solutions.
- Further development of recurring revenue streams through service and support.
Threats
- Global economic slowdown impacting industrial and capital spending.
- Increased competition from both established players and new entrants.
- Supply chain disruptions and raw material cost volatility.
- Changes in regulatory environments affecting its end markets.
- Currency fluctuations impacting international revenues and profits.
Competitors and Market Share
Key Competitors
- Emerson Electric (EMR)
- Honeywell International (HON)
- Thermo Fisher Scientific (TMO)
- Danaher Corporation (DHR)
Competitive Landscape
AMETEK thrives in highly specialized niche markets where it often holds a leading or dominant position. Its competitive advantages stem from its differentiated technologies, strong customer relationships, and ability to integrate acquisitions effectively. While facing competition from larger, more diversified conglomerates, AMETEK's focus on specific high-value segments allows it to command premium pricing and maintain strong profitability.
Major Acquisitions
Creo Medical
- Year: 2023
- Acquisition Price (USD millions): 100
- Strategic Rationale: Strengthens AMETEK's presence in the advanced medical technology sector, expanding its portfolio of innovative medical devices and solutions.
Spectris plc's malvern panalytical business
- Year: 2022
- Acquisition Price (USD millions): 1200
- Strategic Rationale: Enhances AMETEK's Analytical Instruments segment by adding leading particle characterization and materials analysis technologies, serving growing markets in advanced materials and life sciences.
Growth Trajectory and Initiatives
Historical Growth: AMETEK has experienced sustained historical growth, characterized by a compound annual growth rate (CAGR) in revenue and earnings that has often exceeded broader market indices. This growth has been predominantly driven by a disciplined strategy of acquiring and integrating niche businesses with strong market positions.
Future Projections: Analyst consensus generally projects continued solid growth for AMETEK, with expectations of mid-to-high single-digit organic revenue growth and additional growth from strategic acquisitions. Profitability is anticipated to remain strong, with ongoing margin expansion potential.
Recent Initiatives: Recent initiatives include the ongoing execution of its acquisition strategy, focusing on high-margin, technology-driven businesses. AMETEK also emphasizes operational excellence and innovation within its existing portfolio to drive organic growth and maintain competitive advantages.
Summary
AMETEK Inc. is a robust industrial and electronic instrument manufacturer with a strong history of strategic acquisitions and consistent financial performance. Its focus on specialized niche markets provides defensible competitive advantages and drives profitability. While its reliance on acquisitions presents integration risks and its end markets can be cyclical, AMETEK's disciplined approach, technological leadership, and ability to generate strong cash flow position it for continued success. The company needs to remain vigilant regarding global economic conditions and maintain its innovative edge.
Similar Stocks
Sources and Disclaimers
Data Sources:
- AMETEK Inc. official investor relations website
- SEC filings (10-K, 10-Q)
- Financial news and data providers (e.g., Bloomberg, Refinitiv, Yahoo Finance)
- Industry research reports
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. Data is based on publicly available information and may be subject to change. Numerical data for financial metrics and market share is approximate and intended for illustrative purposes. Users should conduct their own due diligence before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ametek Inc
Exchange NYSE | Headquaters Berwyn, PA, United States | ||
IPO Launch date 1984-07-19 | Chairman of the Board & CEO Mr. David A. Zapico | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 21500 | Website https://www.ametek.com |
Full time employees 21500 | Website https://www.ametek.com | ||
AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and metering devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and gas turbines sensors; dashboard instruments for heavy trucks and other vehicles; instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. Its EMG segment offers engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging to protect sensitive electronic devices; precision motion control products for data storage, medical devices, business equipment, and automation; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; and motors for commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers, as well as operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.